Jafron Historical Balance Sheet

300529 Stock

26.32 0.32 1.20%

Trend analysis of Jafron Biomedical Co balance sheet accounts such as Other Current Liab of 5.3 M, Total Current Liabilities of 1 B or Total Stockholder Equity of 3.8 B provides information on Jafron Biomedical's total assets, liabilities, and equity, which is the actual value of Jafron Biomedical to its prevalent stockholders. By breaking down trends over time using Jafron Biomedical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Jafron Biomedical Inventory

464.88 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jafron Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Jafron Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Jafron Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Jafron Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jafron Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jafron currently owns. An asset can also be divided into two categories, current and non-current.

Jafron Biomedical Balance Sheet Chart

At present, Jafron Biomedical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1 B, whereas Other Current Liabilities is forecasted to decline to about 5.3 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of Jafron Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Jafron Biomedical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Jafron Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Jafron Biomedical Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Jafron Biomedical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Jafron Biomedical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jafron Biomedical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	5.5M	4.9M	5.6M	5.3M
Total Assets	5.4B	5.5B	6.4B	6.7B

Other Current Liab Total Assets

Jafron Biomedical balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Deferred Long Term Liab	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Short Term Investments	Non Current Liabilities Total	Common Stock Shares Outstanding	Net Invested Capital
Total Assets		-0.15	0.97	0.98	0.98	0.98	0.96	1.0	0.98	0.61	0.96	0.51	0.96	0.98	0.95	0.99	0.48	0.9	0.97	0.93	0.93	0.86	0.8	0.93	0.73	0.93
Other Current Liab	-0.15		-0.24	0.02	-0.17	-0.02	-0.36	-0.13	-0.05	0.47	-0.38	0.42	-0.36	-0.08	-0.02	-0.11	0.6	0.06	-0.24	-0.06	-0.17	0.25	0.38	-0.41	-0.35	-0.25
Total Current Liabilities	0.97	-0.24		0.91	0.94	0.9	0.99	0.97	0.95	0.43	0.98	0.31	0.98	0.92	0.89	0.94	0.33	0.82	0.93	0.87	0.89	0.78	0.75	0.95	0.79	0.88
Total Stockholder Equity	0.98	0.02	0.91		0.95	0.99	0.89	0.97	0.96	0.75	0.89	0.64	0.87	0.97	0.96	0.98	0.63	0.94	0.94	0.94	0.91	0.9	0.85	0.83	0.63	0.9
Other Liab	0.98	-0.17	0.94	0.95		0.95	0.94	0.97	0.97	0.61	0.95	0.48	0.95	0.95	0.93	0.98	0.44	0.87	0.96	0.91	0.91	0.86	0.75	0.94	0.71	0.92
Retained Earnings	0.98	-0.02	0.9	0.99	0.95		0.89	0.97	0.96	0.72	0.89	0.67	0.89	0.99	0.94	0.99	0.61	0.94	0.97	0.94	0.92	0.89	0.83	0.86	0.64	0.92
Accounts Payable	0.96	-0.36	0.99	0.89	0.94	0.89		0.96	0.92	0.4	0.99	0.3	0.98	0.91	0.88	0.93	0.27	0.8	0.93	0.86	0.89	0.73	0.68	0.96	0.78	0.89
Cash	1.0	-0.13	0.97	0.97	0.97	0.97	0.96		0.98	0.59	0.96	0.48	0.96	0.97	0.94	0.98	0.46	0.89	0.96	0.93	0.92	0.85	0.8	0.93	0.74	0.91
Other Assets	0.98	-0.05	0.95	0.96	0.97	0.96	0.92	0.98		0.64	0.93	0.51	0.94	0.95	0.9	0.97	0.52	0.89	0.95	0.93	0.92	0.92	0.84	0.91	0.69	0.91
Net Receivables	0.61	0.47	0.43	0.75	0.61	0.72	0.4	0.59	0.64		0.39	0.84	0.37	0.64	0.68	0.66	0.89	0.73	0.57	0.66	0.57	0.82	0.72	0.33	0.1	0.55
Inventory	0.96	-0.38	0.98	0.89	0.95	0.89	0.99	0.96	0.93	0.39		0.3	0.99	0.92	0.87	0.94	0.26	0.8	0.95	0.87	0.89	0.73	0.66	0.98	0.79	0.91
Other Current Assets	0.51	0.42	0.31	0.64	0.48	0.67	0.3	0.48	0.51	0.84	0.3		0.29	0.63	0.62	0.59	0.79	0.65	0.55	0.56	0.51	0.63	0.57	0.27	0.09	0.5
Total Liab	0.96	-0.36	0.98	0.87	0.95	0.89	0.98	0.96	0.94	0.37	0.99	0.29		0.91	0.85	0.93	0.23	0.78	0.95	0.86	0.88	0.74	0.65	0.99	0.8	0.9
Intangible Assets	0.98	-0.08	0.92	0.97	0.95	0.99	0.91	0.97	0.95	0.64	0.92	0.63	0.91		0.95	0.99	0.55	0.91	0.97	0.92	0.92	0.85	0.8	0.88	0.69	0.92
Common Stock	0.95	-0.02	0.89	0.96	0.93	0.94	0.88	0.94	0.9	0.68	0.87	0.62	0.85	0.95		0.96	0.53	0.88	0.9	0.89	0.86	0.81	0.78	0.82	0.64	0.86
Property Plant Equipment	0.99	-0.11	0.94	0.98	0.98	0.99	0.93	0.98	0.97	0.66	0.94	0.59	0.93	0.99	0.96		0.52	0.92	0.98	0.93	0.93	0.86	0.79	0.9	0.69	0.93
Good Will	0.48	0.6	0.33	0.63	0.44	0.61	0.27	0.46	0.52	0.89	0.26	0.79	0.23	0.55	0.53	0.52		0.59	0.43	0.49	0.43	0.7	0.7	0.17	0.04	0.37
Net Tangible Assets	0.9	0.06	0.82	0.94	0.87	0.94	0.8	0.89	0.89	0.73	0.8	0.65	0.78	0.91	0.88	0.92	0.59		0.88	0.99	0.96	0.89	0.89	0.75	0.55	0.94
Deferred Long Term Liab	0.97	-0.24	0.93	0.94	0.96	0.97	0.93	0.96	0.95	0.57	0.95	0.55	0.95	0.97	0.9	0.98	0.43	0.88		0.91	0.93	0.81	0.72	0.94	0.71	0.95
Total Current Assets	0.93	-0.06	0.87	0.94	0.91	0.94	0.86	0.93	0.93	0.66	0.87	0.56	0.86	0.92	0.89	0.93	0.49	0.99	0.91		0.98	0.89	0.85	0.83	0.61	0.97
Non Current Assets Total	0.93	-0.17	0.89	0.91	0.91	0.92	0.89	0.92	0.92	0.57	0.89	0.51	0.88	0.92	0.86	0.93	0.43	0.96	0.93	0.98		0.85	0.81	0.86	0.65	0.99
Non Currrent Assets Other	0.86	0.25	0.78	0.9	0.86	0.89	0.73	0.85	0.92	0.82	0.73	0.63	0.74	0.85	0.81	0.86	0.7	0.89	0.81	0.89	0.85		0.9	0.71	0.46	0.82
Short Term Investments	0.8	0.38	0.75	0.85	0.75	0.83	0.68	0.8	0.84	0.72	0.66	0.57	0.65	0.8	0.78	0.79	0.7	0.89	0.72	0.85	0.81	0.9		0.59	0.51	0.75
Non Current Liabilities Total	0.93	-0.41	0.95	0.83	0.94	0.86	0.96	0.93	0.91	0.33	0.98	0.27	0.99	0.88	0.82	0.9	0.17	0.75	0.94	0.83	0.86	0.71	0.59		0.8	0.89
Common Stock Shares Outstanding	0.73	-0.35	0.79	0.63	0.71	0.64	0.78	0.74	0.69	0.1	0.79	0.09	0.8	0.69	0.64	0.69	0.04	0.55	0.71	0.61	0.65	0.46	0.51	0.8		0.67
Net Invested Capital	0.93	-0.25	0.88	0.9	0.92	0.92	0.89	0.91	0.91	0.55	0.91	0.5	0.9	0.92	0.86	0.93	0.37	0.94	0.95	0.97	0.99	0.82	0.75	0.89	0.67

Click cells to compare fundamentals

Jafron Biomedical Account Relationship Matchups

Jafron Biomedical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	3.2B	4.8B	5.4B	5.5B	6.4B	6.7B
Other Current Liab	140.8M	129.3M	5.5M	4.9M	5.6M	5.3M
Total Current Liabilities	330.8M	386.3M	717.2M	829.4M	953.8M	1.0B
Total Stockholder Equity	2.8B	3.4B	3.6B	3.1B	3.6B	3.8B
Other Liab	51.1M	61.5M	52.2M	125.8M	144.7M	151.9M
Retained Earnings	1.7B	2.3B	2.1B	2.0B	2.3B	2.4B
Accounts Payable	50.2M	60.8M	128.5M	135.6M	156.0M	163.8M
Cash	1.6B	2.3B	2.6B	2.8B	3.2B	3.4B
Other Assets	107.9M	102.4M	91.6M	225.4M	259.2M	272.2M
Net Receivables	167.4M	269.1M	221.7M	74.9M	86.1M	115.1M
Inventory	120.7M	196.5M	349.1M	385.0M	442.7M	464.9M
Other Current Assets	65.3M	75.3M	35.6M	17.3M	19.8M	26.1M
Total Liab	383.1M	1.4B	1.8B	2.4B	2.7B	2.9B
Intangible Assets	89.9M	101.3M	100.4M	100.4M	115.4M	121.2M
Common Stock	417.3M	418.7M	799.1M	805.5M	926.3M	972.6M
Property Plant Equipment	457.6M	639.6M	905.5M	1.3B	1.5B	1.5B
Net Tangible Assets	1.6B	2.1B	2.7B	3.2B	3.7B	2.0B
Deferred Long Term Liab	3.4M	14.8M	20.4M	36.0M	41.3M	43.4M
Total Current Assets	2.0B	3.1B	3.3B	3.3B	3.8B	2.1B
Non Current Assets Total	1.2B	1.8B	2.1B	2.2B	2.6B	1.3B
Non Currrent Assets Other	58.2M	162.8M	148.2M	107.0M	123.0M	102.3M
Non Current Liabilities Total	52.2M	1.0B	1.1B	1.6B	1.8B	1.9B
Common Stock Shares Outstanding	799.1M	805.5M	807.7M	807.6M	928.7M	880.0M
Net Invested Capital	2.8B	4.3B	4.8B	4.8B	5.5B	3.4B
Net Working Capital	1.7B	2.7B	2.6B	2.5B	2.9B	2.0B
Capital Stock	799.1M	805.5M	807.7M	807.6M	928.7M	743.6M
Property Plant And Equipment Net	905.5M	1.3B	1.7B	1.8B	2.0B	1.4B
Property Plant And Equipment Gross	1.0B	1.4B	1.9B	2.1B	2.4B	1.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Jafron Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jafron Historical Balance Sheet

Jafron Biomedical Inventory

464.88 Million

About Jafron Balance Sheet Analysis

Jafron Biomedical Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Jafron Biomedical balance sheet Correlations

Jafron Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Jafron Biomedical balance sheet Accounts

Also Currently Popular

Other Information on Investing in Jafron Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Total Current Liabilities
Retained Earnings	+ 0.99	Total Stockholder Equity
Intangible Assets	+ 0.99	Retained Earnings
Property Plant Equipment	+ 0.99	Retained Earnings

Non Current Liabilities Total	- 0.41	Other Current Liab
Inventory	- 0.38	Other Current Liab
Total Liab	- 0.36	Other Current Liab
Accounts Payable	- 0.36	Other Current Liab
Common Stock Shares Outstanding	- 0.35	Other Current Liab
Net Invested Capital	- 0.25	Other Current Liab